Physician profile
Bruce Stuart Allen
NPI 1558603969
$2,302.92
in general payments reported to CMS, 2019-2025
16 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,139 · 2020: $93.08 · 2021: $123 · 2022: $252 · 2023: $329 · 2024: $260 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $566.41 | 2022-2025 | |
| Abbvie INC. | $471.25 | 2019-2024 | Rinvoq, Vraylar |
| Novartis Pharmaceuticals Corporation | $216.60 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $197.25 | 2019 | |
| Lilly USA, LLC | $137.52 | 2022-2025 | Jardiance |
| Helsinn Therapeutics (U.S.), INC. | $124.60 | 2019 | |
| Biofrontera INC. | $119.22 | 2019 | |
| Celgene Corporation | $110.16 | 2019 | |
| Allergan, INC. | $97.33 | 2019 | |
| Sanofi-Aventis U.S. LLC | $93.08 | 2020 | |
| Galderma Laboratories, L.P. | $66.26 | 2019-2023 | Dysport |
| Exact Sciences Corporation | $34.74 | 2023-2024 | Cologuard Collection Kit |
| Genzyme Corporation | $18.20 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.39 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.82 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $16.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.